“ADJUVANT XELOX CHEMOTHERAPY OUTCOMES IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: EVIDENCE FROM THAI BINH GENERAL HOSPITAL”, YHCĐ, vol. 67, no. 10, Oct. 2026, doi: 10.52163/yhc.v67i10.6908.